Back
Speaker illustration

Ms Kathrine Kold Soerensen

North Zealand University Hospital, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Presentations

Cardiovascular outcomes in sustained use of glucagon like peptide inhibitors: a trial inspired population vs. a broad population

Event: ESC Congress 2025

Topic: Antidiabetic Pharmacotherapy

Session: What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?

Access
Like
Thumbnail

GLP1-RA versus DPP4 inhibitors on cardiovascular outcomes: A three-year real-world analysis

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: Diabetes, obesity, and the heart

Access
Like
Thumbnail

GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study

Event: ESC Congress 2023

Topic: Antidiabetic Pharmacotherapy

Session: Antidiabetic medications and cardiovascular disease

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources